University of Minnesota. Driven to Discover.
The WHO's director-general today warned that 'red zones' in conflict areas could be hiding places for Ebola.
About 4% of patients traveled, a potential target for curbing disease spread.
The phase 2 trials will enroll more than 5,000 adults and kids in Guinea and Liberia.
Sierra Leone reports no cases after having 5 last week, and new funds for drugs and vaccines are announced.
As cases drop slightly, vaccine trials suffer from lack of patients. Also, the NIH announces a trial involving survivors.
Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.
The findings clear the way for the next step, which may require a change in venue.
The virus may be more stable than a study in August found.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2021 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.